BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 33632567)

  • 1. Optic neuropathy by ethambutol in a patient with multiple sclerosis.
    Gómez-Calleja V; Pérez-García P; Ly-Yang F; Santos-Bueso E
    Arch Soc Esp Oftalmol (Engl Ed); 2021 Feb; ():. PubMed ID: 33632567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optic neuropathy by ethambutol in a patient with multiple sclerosis.
    Gómez-Calleja V; Pérez-García P; Ly-Yang F; Santos-Bueso E
    Arch Soc Esp Oftalmol (Engl Ed); 2022 Jan; 97(1):52-57. PubMed ID: 35027147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optical coherence tomography can measure axonal loss in patients with ethambutol-induced optic neuropathy.
    Zoumalan CI; Agarwal M; Sadun AA
    Graefes Arch Clin Exp Ophthalmol; 2005 May; 243(5):410-6. PubMed ID: 15565293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ethambutol-induced optic neuropathy.
    Kyncl M; Fus M; Lestak J
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2023 Sep; 167(3):288-293. PubMed ID: 35582729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased retinal nerve fibre layer thickness detected by optical coherence tomography in patients with ethambutol-induced optic neuropathy.
    Chai SJ; Foroozan R
    Br J Ophthalmol; 2007 Jul; 91(7):895-7. PubMed ID: 17215265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Ethambutol-induced toxic optic neuropathy during treatment of tuberculosis meningitis in a child].
    Krichene MA; Hassina S; Mrad K; Hasnaoui I; Serghini L; Abdallah E; Berraho HA
    J Fr Ophtalmol; 2023 Jun; 46(6):658-661. PubMed ID: 37208267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Severe and reversible optic neuropathy by ethambutol and isoniazid].
    Rodríguez-Marco NA; Solanas-Alava S; Ascaso FJ; Martínez-Martínez L; Rubio-Obanos MT; Andonegui-Navarro J
    An Sist Sanit Navar; 2014; 37(2):287-91. PubMed ID: 25189987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early stage ethambutol optic neuropathy: retinal nerve fiber layer and optical coherence tomography.
    Kim U; Hwang JM
    Eur J Ophthalmol; 2009; 19(3):466-9. PubMed ID: 19396796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Debut of Leber's hereditary optic neuropathy. Macular segmentation analysis using optical coherence tomography].
    Santos-Bueso E; Asorey-García A; Porta-Etessam J; Vinuesa-Silva JM; García-Sánchez J
    Arch Soc Esp Oftalmol; 2015 May; 90(5):233-6. PubMed ID: 25443199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxic optic neuropathy due to voriconazole: possible potentiation by reduction of CYP2C19 activity.
    Orssaud C; Guillemain R; Lillo Le Louet A
    Eur Rev Med Pharmacol Sci; 2021 Dec; 25(24):7823-7828. PubMed ID: 34982443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ethambutol-associated optic neuropathy.
    Lim SA
    Ann Acad Med Singap; 2006 Apr; 35(4):274-8. PubMed ID: 16710500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple sclerosis in ophthalmology: beyond optic neuritis.
    Alcubierre R; Sánchez-Dalmau BF; Muñoz S
    Med Clin (Barc); 2020 Jul; 155(2):70-76. PubMed ID: 32404264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ethambutol induced toxic optic neuropathy - A retrospective study in a tertiary eye care centre in Southern India.
    Shanmugam MK; Sajja S; Kowsalya A; Balakrishnan HK; Jayasri KN
    Nepal J Ophthalmol; 2022 Jul; 14(28):108-115. PubMed ID: 37609972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optic neuritis in pediatric population: a review in current tendencies of diagnosis and management.
    Pérez-Cambrodí RJ; Gómez-Hurtado Cubillana A; Merino-Suárez ML; Piñero-Llorens DP; Laria-Ochaita C
    J Optom; 2014; 7(3):125-30. PubMed ID: 25000867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optic neuropathy induced by ethambutol: A rare case from Nepal.
    Shah S; Adhikari YR; Paudel S; Sitaula S; Koirala B; Aryal S; Pande Y; Karki R
    Ann Med Surg (Lond); 2022 May; 77():103637. PubMed ID: 35638034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optic neuropathies post-Covid 19 - review.
    Abdul-Salam State SE; Sfredel V; Mocanu CL; Albu CV; Bălășoiu AT
    Rom J Ophthalmol; 2022; 66(4):289-298. PubMed ID: 36589322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longitudinal analysis of retinal nerve fiber layer and ganglion cell-inner plexiform layer thickness in ethambutol-induced optic neuropathy.
    Han J; Byun MK; Lee J; Han SY; Lee JB; Han SH
    Graefes Arch Clin Exp Ophthalmol; 2015 Dec; 253(12):2293-9. PubMed ID: 26344730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ethambutol-induced optic neuropathy in renal disorder: a clinico-electrophysiological study.
    Kanaujia V; Jain VK; Sharma K; Agarwal R; Mishra P; Sharma RK
    Can J Ophthalmol; 2019 Jun; 54(3):301-305. PubMed ID: 31109468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ethambutol-induced optic neuropathy: Functional and structural changes in the retina and optic nerve.
    Sen S; Mandal S; Banerjee M; Gk R; Saxena A; Aalok SP; Saxena R
    Semin Ophthalmol; 2022 Aug; 37(6):730-739. PubMed ID: 35699333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macular thickness as a predictor of loss of visual sensitivity in ethambutol-induced optic neuropathy.
    Peng CX; Zhang AD; Chen B; Yang BJ; Wang QH; Yang M; Wei SH
    Neural Regen Res; 2016 Mar; 11(3):469-75. PubMed ID: 27127488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.